04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
On January 17, 2020, the Committee on Foreign Investment in the United States (“CFIUS”) published ...
Read More >
The Third Circuit Court of Appeals recently issued an opinion upholding the right of a former bank e...
Read More >
Wilson Sonsini Goodrich & Rosati (Wilson Sonsini) is pleased to present its 2019 Antitrust Year in R...
Read More >
Advisors ask me all the time of the role of education in participant-directed 401(k) plans. Particip...
Read More >
On October 11, 2019, the Office of Federal Contract Compliance Programs (OFCCP) published to its web...
Read More >
Buyers of assets typically like to pick and choose the assets and liabilities that they will acquire...
Read More >